NCT05671172View on ClinicalTrials.gov

Effect of Adding Hyaluronidase to Bupivacaine in Transversus Abdominis Plane Block for Cesarean Section

NACompletedINTERVENTIONAL

Enrollment

114

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

January 10, 2024

Study Completion Date

February 10, 2024

Conditions

Pain, Postoperative

Interventions

DRUG

Hyaluronidase

hyaluronidase will be applied as adjuvant to bupivacaine in transversus abdominis plane block to enhance the postoperative analgesic effect after CS

DRUG

Bupivacaine Injection

20ml bupivacaine will be injected without additives in the transversus abdominis plane block on each side for postoperative analgesic after CS

Trial Locations (1)

13511

Samar Rafik Amin, Banhā

All Listed Sponsors

lead

Benha University

OTHER

NCT05671172 - Effect of Adding Hyaluronidase to Bupivacaine in Transversus Abdominis Plane Block for Cesarean Section | Biotech Hunter | Biotech Hunter